SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-061461
Filing Date
2021-03-01
Accepted
2021-02-26 20:01:18
Documents
15
Effectiveness Date
2021-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 d105256ds8.htm S-8 113288
2 EX-4.1 d105256dex41.htm EX-4.1 617484
3 EX-5.1 d105256dex51.htm EX-5.1 1680
4 EX-23.1 d105256dex231.htm EX-23.1 9870
5 EX-99.1 d105256dex991.htm EX-99.1 199746
6 EX-99.2 d105256dex992.htm EX-99.2 45454
7 EX-99.3 d105256dex993.htm EX-99.3 26104
8 EX-99.4 d105256dex994.htm EX-99.4 26283
9 EX-99.5 d105256dex995.htm EX-99.5 17333
10 EX-99.6 d105256dex996.htm EX-99.6 16851
11 GRAPHIC g105256dsp17.jpg GRAPHIC 5448
12 GRAPHIC g105256dsp17a.jpg GRAPHIC 2009
13 GRAPHIC g105256dsp3.jpg GRAPHIC 3758
14 GRAPHIC g105256g31s60.jpg GRAPHIC 2251
15 GRAPHIC g105256g33y70.jpg GRAPHIC 3657
  Complete submission text file 0001193125-21-061461.txt   1099391
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filer) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-253670 | Film No.: 21693074
SIC: 2833 Medicinal Chemicals & Botanical Products